Norris Medicines

  • Market Cap: Micro Cap
  • Industry: Trading & Distributors
  • ISIN: INE744C01029
  • NSEID:
  • BSEID: 524414
INR
14.08
0.01 (0.07%)
BSENSE

Nov 20

BSE+NSE Vol: 121

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 210607,
    "name": "Norris Medicines",
    "stock_name": "Norris Medicines",
    "full_name": "Norris Medicines Ltd",
    "name_url": "stocks-analysis/norris-medicines",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "14.08",
    "chg": 0.01,
    "chgp": "0.07%",
    "dir": 1,
    "prev_price": "14.07",
    "mcapval": "14.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524414,
    "symbol": "",
    "ind_name": "Trading & Distributors",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE744C01029",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "121 ",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/norris-medicines-210607-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Norris Medicines Ltd Downgraded to Strong Sell Amid Technical and Fundamental Weaknesses",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/norris-medicines-ltd-downgraded-to-strong-sell-amid-technical-and-fundamental-weaknesses-4240346",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/NorrisMedicines_mojoScore_4240346.png",
        "date": "2026-10-27 08:53:53",
        "description": "Norris Medicines Ltd, a micro-cap player in the Trading & Distributors sector, has been downgraded from a Sell to a Strong Sell rating by MarketsMOJO as of 26 Oct 2026. This revision reflects deteriorating technical indicators, weak financial trends, poor valuation metrics, and declining quality scores, signalling heightened risk for investors amid a challenging market environment."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Norris Medicines Ltd to 52-Week High of Rs 20.06",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/norris-medicines-ltd-hits-new-52-week-high-at-rs2006-4204512",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/NorrisMedicines_priceRelatedfactors_4204512.png",
        "date": "2026-09-25 09:43:05",
        "description": "With a fresh 52-week high of Rs 20.06 reached on 25 Sep 2026, Norris Medicines Ltd has demonstrated notable price momentum, outperforming the broader market which remains subdued near its own lows."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Norris Medicines Ltd to 52-Week High of Rs 19.71",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/norris-medicines-ltd-hits-new-52-week-high-at-rs1971-4200841",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/NorrisMedicines_priceRelatedfactors_4200841.png",
        "date": "2026-09-22 09:44:05",
        "description": "Surging to a new 52-week high of Rs 19.71 on 22 Sep 2026, Norris Medicines Ltd has demonstrated remarkable price momentum, outperforming its sector by 4.94% today and extending a seven-day winning streak that has delivered a 35.93% return. This rally stands out amid a broader market environment where the Sensex remains subdued, trading near its 52-week low and below key moving averages."
      }
    ],
    "total": 12,
    "sid": "210607",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/norris-medicines-210607"
  },
  "announcements": [
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. Saturday November 14 2026",
      "datetime": "14-Nov-2026",
      "details": "Outcome Of Board Meeting Held Today I.E. Saturday November 14 2026",
      "source": "BSE"
    },
    {
      "caption": " Un-Audited Financial Results For The Quarter And Half Year Ended 30Th September 2026",
      "datetime": "14-Nov-2026",
      "details": "Un-audited financial results for the quarter and half year ended 30th September 2026",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Holding Board Meeting For Approval Of Un-Audited Financial Results For The Quarter And Half Year Ended September 30Th 2026 And Other Matters.",
      "datetime": "06-Nov-2026",
      "details": "Norris Medicines Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 inter alia to consider and approve Un-Audited Financial Results For the Quarter and half year ended September 30th 2026 And Other Matters.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock-recommendationAnnouncement

Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. Saturday November 14 2026

14-Nov-2026 | Source : BSE

Outcome Of Board Meeting Held Today I.E. Saturday November 14 2026

Un-Audited Financial Results For The Quarter And Half Year Ended 30Th September 2026

14-Nov-2026 | Source : BSE

Un-audited financial results for the quarter and half year ended 30th September 2026

Board Meeting Intimation for Holding Board Meeting For Approval Of Un-Audited Financial Results For The Quarter And Half Year Ended September 30Th 2026 And Other Matters.

06-Nov-2026 | Source : BSE

Norris Medicines Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 inter alia to consider and approve Un-Audited Financial Results For the Quarter and half year ended September 30th 2026 And Other Matters.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available